Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Operating Leases (2019 - 2025)

Historic Operating Leases for Cue Biopharma (CUE) over the last 7 years, with Q3 2025 value amounting to $2.7 million.

  • Cue Biopharma's Operating Leases rose 10241.33% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 10241.33%. This contributed to the annual value of $1.0 million for FY2024, which is 6827.96% down from last year.
  • Latest data reveals that Cue Biopharma reported Operating Leases of $2.7 million as of Q3 2025, which was up 10241.33% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Cue Biopharma's Operating Leases registered a high of $6.8 million during Q2 2022, and its lowest value of $176000.0 during Q1 2025.
  • In the last 5 years, Cue Biopharma's Operating Leases had a median value of $3.2 million in 2023 and averaged $3.5 million.
  • Per our database at Business Quant, Cue Biopharma's Operating Leases surged by 45927.84% in 2021 and then tumbled by 9317.56% in 2025.
  • Over the past 5 years, Cue Biopharma's Operating Leases (Quarter) stood at $5.1 million in 2021, then increased by 17.51% to $6.0 million in 2022, then crashed by 47.46% to $3.2 million in 2023, then tumbled by 68.28% to $1.0 million in 2024, then surged by 167.6% to $2.7 million in 2025.
  • Its Operating Leases was $2.7 million in Q3 2025, compared to $3.1 million in Q2 2025 and $176000.0 in Q1 2025.